Oxitec’s technology for combatting dengue fever by releasing sterile mosquitoes into the wild will be applied to other insect-borne diseases by new owner Intrexon
The first paper describing this now world-leading class of therapeutics was published in August 1985. Since then, the UK Medical Research Council has received more than £580M in royalties
While it has a high reputation for the quality of its basic medical research, Poland lacks the means to translate this into the clinic. International collaboration is needed to help build this infrastructure